The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2023 | Session highlights at COMy 2023: latest updates in myeloma disease biology & pathophysiology
Enrique Ocio, MD, PhD, Marqués de Valdecilla University Hospital, Santander, Spain, gives an overview of topics presented in a session at COMy 2023 which focused on updates in myeloma disease biology and pathophysiology. This session covered a wide range of topics, including the genomic complexity of multiple myeloma, the role of the microenvironment in disease progression, mechanisms of resistance to immune-based therapies, and the role of the microbiome in disease. This interview took place at the 9th World Congress on Controversies in Multiple Myeloma (COMy) 2023, held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
